These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2326771)

  • 1. Protective effect of Y-20811, a long-lasting thromboxane synthetase inhibitor, on endotoxin shock in rabbits.
    Mikashima H; Muramoto Y
    Thromb Res; 1990 Feb; 57(4):499-505. PubMed ID: 2326771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
    Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
    Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
    Halushka PV; Cook JA; Wise WC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do prostacyclin and thromboxane play a role in endotoxic shock?
    Webb PJ; Westwick J; Scully MF; Zahavi J; Kakkar VV
    Br J Surg; 1981 Oct; 68(10):720-4. PubMed ID: 7025959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance between plasma levels of thromboxane B2 and 6-keto-prostaglandin F1 alpha during subacute endotoxin-induced hyperdynamic sepsis or multiple organ failure syndrome in sheep.
    Pittet JF; Morel DR
    Circ Shock; 1991 Oct; 35(2):65-77. PubMed ID: 1777948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of aspirin in endotoxic shock.
    Halushka PV; Wise WC; Cook JA
    J Pharmacol Exp Ther; 1981 Aug; 218(2):464-9. PubMed ID: 6894770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anisodamine on plasma levels of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) in rat with septic shock.
    Tao YP; Xiao DM; Chen HC
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):116-7. PubMed ID: 3194375
    [No Abstract]   [Full Text] [Related]  

  • 10. CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
    Olson RW; Cohen DS; Ku EC; Kimble EF; Renfroe HB; Smith EF
    Eur J Pharmacol; 1987 Jan; 133(3):265-73. PubMed ID: 3104066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of thromboxane in primate endotoxin shock.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Surg Res; 1985 Aug; 39(2):140-9. PubMed ID: 3839548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
    Anderegg K; Anzeveno P; Cook JA; Halushka PV; McCarthy J; Wagner E; Wise WC
    Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).
    Randall MJ; Wilding RI
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):49S-55S. PubMed ID: 6687429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs.
    Matsumoto Y; Ochi H; Aihara K; Inui J; Ikegami K
    Eur J Pharmacol; 1992 Mar; 213(2):167-70. PubMed ID: 1521557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
    Moore JN; Hardee MM; Hardee GE
    Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock.
    Ball HA; Cook JA; Wise WC; Halushka PV
    Intensive Care Med; 1986; 12(3):116-26. PubMed ID: 3016060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective thromboxane synthetase inhibition by picotamide and effects on endotoxin-induced lethality.
    Matera G; Chisari M; Altavilla D; Foca A; Cook JA
    Proc Soc Exp Biol Med; 1988 Jan; 187(1):58-61. PubMed ID: 3277192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01).
    Randall MJ; Wilding RI
    Thromb Res; 1982 Dec; 28(5):607-16. PubMed ID: 6897751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the beneficial effects of aspirin in endotoxic shock. Relationship to inhibition of arachidonic acid metabolism.
    Halushka PV; Wise WC; Cook JA
    Am J Med; 1983 Jun; 74(6A):91-6. PubMed ID: 6687979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.